• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,142
109
75
71
68

COUNTRY

70
22
16
10
9

CATEGORIES

  • 574
  • 119
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

970
1,200
1,765
2,986

PUBLISHED

43
223
668
2,986

PRODUCT TYPE

2,412
494
70
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE
Malignant Neoplasms - Pipeline Review, H1 2013 Malignant Neoplasms - Pipeline Review, H1 2013 - Product Thumbnail Image

Malignant Neoplasms - Pipeline Review, H1 2013

Malignant Neoplasms – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Malignant Neoplasms - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Peritoneal Cancer - Pipeline Review, H1 2013 Peritoneal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Peritoneal Cancer - Pipeline Review, H1 2013

Peritoneal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Peritoneal Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Metastatic Colorectal Cancer - Pipeline Review, H1 2013 Metastatic Colorectal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Review, H1 2013

Metastatic Colorectal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Colorectal Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Metastatic Pancreatic Cancer - Pipeline Review, H1 2013 Metastatic Pancreatic Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Pancreatic Cancer - Pipeline Review, H1 2013

Metastatic Pancreatic Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Pancreatic Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Colon Cancer - Pipeline Review, H1 2013 Colon Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Colon Cancer - Pipeline Review, H1 2013

Colon Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013 Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013

Metastatic Renal Cell Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Malignant Mesothelioma - Pipeline Review, H1 2013 Malignant Mesothelioma - Pipeline Review, H1 2013 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Review, H1 2013

Malignant Mesothelioma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Malignant Mesothelioma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Myelodysplastic Syndrome - Pipeline Review, H1 2013 Myelodysplastic Syndrome - Pipeline Review, H1 2013 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2013

Myelodysplastic Syndrome – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Myelodysplastic Syndrome - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Oral Mucositis - Pipeline Review, H1 2013 Oral Mucositis - Pipeline Review, H1 2013 - Product Thumbnail Image

Oral Mucositis - Pipeline Review, H1 2013

Oral Mucositis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oral Mucositis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Melanoma - Pipeline Review, H1 2013 Melanoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2013

Melanoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Melanoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

February 2013
FROM
Endometrial Cancer - Pipeline Review, H1 2013 Endometrial Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Endometrial Cancer - Pipeline Review, H1 2013

Endometrial Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Endometrial Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM
Ewing Sarcoma - Pipeline Review, H1 2013 Ewing Sarcoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Ewing Sarcoma - Pipeline Review, H1 2013

Ewing Sarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ewing Sarcoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

February 2013
FROM
Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2013 Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2013

Squamous Non-Small Cell Lung Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s...

February 2013
FROM
Natural Killer Cell Lymphomas - Pipeline Review, H1 2013 Natural Killer Cell Lymphomas - Pipeline Review, H1 2013 - Product Thumbnail Image

Natural Killer Cell Lymphomas - Pipeline Review, H1 2013

Natural Killer Cell Lymphomas – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Natural Killer Cell Lymphomas - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM
Oncology Drug Pipeline Update (Premium) Oncology Drug Pipeline Update (Premium) - Product Thumbnail Image

Oncology Drug Pipeline Update (Premium)

Extra value: One year of free online updates included with this product With the Oncology Drug Pipeline Update (Premium) you will have life time desktop access to competitive drug information for almost...

February 2013
Oncology Drug Pipeline Update (Premium) - Online Oncology Drug Pipeline Update (Premium) - Online - Product Thumbnail Image

Oncology Drug Pipeline Update (Premium) - Online

With the Oncology Drug Pipeline Update (Premium) you will have online access to competitive drug information for almost 6,000 drugs across 120 indications in oncology via our intuitive guided searches,...

February 2013
The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers - Product Thumbnail Image

The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers

The report contains 1,200 pages, 450 tables, and provides test volume and sales forecasts for major tumor markers, as well as supplier sales and shares by test, market segment and country Available...

February 2013
FROM
2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers 2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers - Product Thumbnail Image

2013 Analysis of the Global Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers

This new report from Venture Planning Group provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic...

February 2013
FROM

IVD Procedure Volume and Pricing Analysis

IVD Procedure Volume and Pricing Analysis This report examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are...

January 2013
FROM
Global Lung Cancer Therapeutics Market 2012-2016 Global Lung Cancer Therapeutics Market 2012-2016 - Product Thumbnail Image

Global Lung Cancer Therapeutics Market 2012-2016

TechNavio's analysts forecast the Global Lung Cancer Therapeutics market to grow at a CAGR of 13.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the...

January 2013
FROM
Loading Indicator

Our Clients

Our clients' logos